Cargando…
Factors Influencing the Risk of Major Amputation in Patients with Diabetic Foot Ulcers Treated by Autologous Cell Therapy
INTRODUCTION: Autologous cell therapy (ACT) is one of the last options for limb salvage in patients with chronic limb-threatening ischemia (CLTI) and diabetic foot ulcers (DFU). However, some patients may still undergo a major amputation even after ACT, but the risk factors for this are not known. T...
Autores principales: | Husakova, J., Bem, R., Fejfarova, V., Jirkovska, A., Woskova, V., Jarosikova, R., Lovasova, V., Jude, E. B., Dubsky, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017448/ https://www.ncbi.nlm.nih.gov/pubmed/35450383 http://dx.doi.org/10.1155/2022/3954740 |
Ejemplares similares
-
Effects of a 12-Week Interventional Exercise Programme on Muscle Strength, Mobility and Fitness in Patients With Diabetic Foot in Remission: Results From BIONEDIAN Randomised Controlled Trial
por: Vrátná, Eliška, et al.
Publicado: (2022) -
Microdialysis as a tool for antibiotic assessment in patients with diabetic foot: a review
por: Fejfarová, Vladimíra, et al.
Publicado: (2023) -
Stimulation TcPO2 Testing Improves Diagnosis of Peripheral Arterial Disease in Patients With Diabetic Foot
por: Fejfarová, Vladimíra, et al.
Publicado: (2021) -
Comparison of the impact of autologous cell therapy and conservative standard treatment on tissue oxygen supply and course of the diabetic foot in patients with chronic limb-threatening ischemia: A randomized controlled trial
por: Dubský, Michal, et al.
Publicado: (2022) -
Difference in Serum Endostatin Levels in Diabetic Patients with Critical Limb Ischemia Treated by Autologous Cell Therapy or Percutaneous Transluminal Angioplasty
por: Nemcova, Andrea, et al.
Publicado: (2018)